Ziemer Ophthalmic Systems AG
Port, Switzerland
NCT Number: NCT03396003
The purpose of this study is to compare the Ziemer Ophthalmic Systems AG GALILEI G6 Lens Professional to the Oculus Pentacam® AXL for taking images and measurements of the anterior segment of the eye, including the cornea, pupil, anterior chamber and lens, to assist in determining the power of the intraocular lens for implantation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Port, Switzerland
A corneal topographer/biometer named GALILEI G6 Lens Professional was developed by Ziemer Ophthalmic Systems AG for the measurement of anterior segment geometry and axial intraocular distances. The measurement principle of the corneal topographer corresponds to that of the commercially available Galilei G4 Dual Scheimpflug Analyzer, whereas the measurement principle of the biometer is based on low coherence interferometry/reflectometry, which has been widely used and applied clinically by a number of predicate devices.
One complete measurement consists of a corneal topography/ tomography scan followed by three consecutive, axial biometry scans of the anterior segment (cornea and crystalline lens) and three consecutive, axial biometry scans of the retina. The measurement process is continuous but divided into three alignment-click-steps.
Such measurements can be applied to given Intra Ocular Lens (IOL) types and IOL equations, to permit the calculation of recommended IOLs to be implanted during cataract surgery in order to achieve the desired vision correction.
The primary objectives of this clinical study are to: 1) evaluate the inter-device repeatability, inter-operator repeatability and reproducibility of the GALILEI G6 Lens Professional in repeated measurements of anterior segment geometry and axial intraocular distances and, 2) demonstrate substantial equivalence through examining agreement of the GALILEI measurements to those of the predicate device, the Pentacam® AXL.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eight measurements of the eye using the GALILEI G6 Lens Professional will be taken using two different devices and 2 different operators
A single measurement of the eye will be taken using the Oculus Pentacam AXL
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Time frame: One day
Repeatability and reproducability across and between evaluations
Ziemer Ophthalmic Systems AG
Industry
GALILEI G6 Lens Professional vs. a Predicate Device: a Comparison Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735000
Age Related Cataract, Cataract
Peshawar, KPK, Pakistan
View Trial DetailsNCT07605260
Cataract, Eye Diseases
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT06428955
Cataract, Eye Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT06111222
Cataract, Eye Diseases
Heidelberg, Germany
View Trial Details